Latest News for: immunoglobulin e

Edit

Creative Biolabs Pioneers a New Era in Protein Research and Immunoglobulin Discovery

GetNews 07 Jan 2025
Through state-of-the-art protein research or trailblazing developments in antibody discovery, Creative Biolabs is further changing the possibilities of therapeutic development. New York, USA - January 7, 2025 - Industry Context ... Ribosome Profiling ... .
Edit

Intravenous Immunoglobulin Market Size Expands Driven by Integration of Smart Solutions

Pharmiweb 29 Nov 2024
The Intravenous Immunoglobulin market has experienced remarkable growth over recent years, driven by advancements in medical technologies, increasing awareness of immune-related disorders, and rising healthcare expenditures.
Edit

Sparsentan approved to treat adult patients with primary immunoglobulin A nephropathy (IgAN) (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 18 Nov 2024
) News story Sparsentan approved to treat adult patients with primary immunoglobulin A nephropathy (IgAN) ... the medicine sparsentan (Filspari) to treat primary immunoglobulin A nephropathy (IgAN).
Edit

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin ...

Nasdaq Globe Newswire 12 Nov 2024
-INDIGO is the largest clinical trial conducted in patients living with IgG4-RD- ... .
Edit

Unveiling the secrets of aging: Scientists discover dual role of immunoglobulins

Phys Dot Org 10 Nov 2024
A team of scientists from the Chinese Academy of Sciences (CAS) and BGI Research has uncovered the intricate mechanisms by which immunoglobulins influence the aging process, a finding that might reshape our understanding of aging.
Edit

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced ...

Nasdaq Globe Newswire 22 Oct 2024
... ocular surface immunoglobulin (OSIG) eye drops for their ability to treat ocular damage from sulfur mustard exposure.
Edit

Human Immunoglobulin Market to Grow by USD 9.69 Billion from 2024-2028, Driven by Increased Plasma ...

Longview News-Journal 11 Sep 2024
NEW YORK, Sept. 11, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global human immunoglobulin market size is estimated to grow by USD 9.69 billion from 2024-2028, according to Technavio. The market is estimated to grow ....
Edit

Human Immunoglobulin Market to Grow by USD 9.69 Billion from 2024-2028, Driven by Increased Plasma Donations, Report Highlights AI's Role in Market Transformation - Technavio

PR Newswire 11 Sep 2024
Derived from pooled human plasma, human immunoglobulins, such as Intravenous Immunoglobulin (IVIG), are vital for treating immune deficiencies and autoimmune disorders ... Subcutaneous Immunoglobulin ...
Edit

Immunoglobulin Market Size To Hit US$ US$ 24.9 Billion By 2032 Grow CAGR By 5.1%

MENA FN 18 Jul 2024
(MENAFN - EIN Presswire) Immunoglobulin Market Size to Hit US$ US$ 24.9 Billion by 2032 . Grow CAGR by 5.1% UNITED STATES, July 17, 2024 /EINPresswire / -- IMARC Group's report titled ... .
Edit

Immunoglobulins Market Size & Share to Surpass USD 27.7 Billion by 2031, Projected a CAGR of 6.2% | Report by Transparency Market Research, Inc.

PR Newswire 16 Jul 2024
Stringent quality control measures ensure the safety, purity, and consistency of immunoglobulin products, fostering trust and confidence among stakeholders ... Immunoglobulins Market Report Scope. ... Global Immunoglobulins Market.
Edit

Kedrion Selected by Biotest to Distribute its Immunoglobulin Yimmugo® in the U.S. Following Recent FDA Approval

PR Newswire 01 Jul 2024
As Kedrion currently distributes two of the fastest-growing injectable immunoglobulin (IG) therapies in the U.S., the company is well-positioned for successful commercialization and distribution of Yimmugo®.
Edit

Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion

Pharmiweb 01 Jul 2024
Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion ... Yimmugo® will complement other leading Grifols Group immunoglobulin therapeutics.

Most Viewed

×